Exercise During Chemotherapy Treatment As Adjuvant Program in Patients with Lymphoma: EDONOLA Study.
Trial Parameters
Brief Summary
In people diagnosed with lymphoma receiving immunochemotherapy treatment, a combined exercise intervention, as opposed to the general recommendations, will achieve: 1.Improve cardiorespiratory fitness, strength, psychological well-being and quality of life. //2.Reduce fatigue//3.Reduce frailty There is an association between some biological biomarkers with physical capacity and frailty.
Eligibility Criteria
Inclusion Criteria: * Age: ≥18 years old. * Diagnosis of lymphoma with histological confirmation and requirement of systemic treatment including chemotherapy. * Time available (80 minutes, two days a week for 20 weeks) to carry out physical exercise sessions. * Have a mobile phone to be able to contact the person and download the physical activity level app. * Eastern Cooperative Oncology Group performance status (ECOG) ≤2. * Life expectancy \>12 months. * Availability and desire to participate throughout the study period. Exclusion Criteria: * Have a contraindication to moderate-high intensity exercise. * Other significant medical disorders: including psychiatric illnesses chronic or recurrent; intellectual disability, musculoskeletal problems, cardiac or pulmonary disorders that interfere with physical exercise; other malignant tumors in the last five years, with the exception of therapeutically controlled skin cancer; any other illness that may be seen affected or aggravated